Traders Purchase High Volume of SIGA Technologies Call Options (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) was the target of unusually large options trading activity on Wednesday. Investors bought 1,200 call options on the company. This is an increase of approximately 1,438% compared to the typical daily volume of 78 call options.

Institutional Trading of SIGA Technologies

A number of institutional investors have recently made changes to their positions in the business. Principal Financial Group Inc. acquired a new position in SIGA Technologies during the third quarter worth $149,000. Victory Capital Management Inc. increased its holdings in SIGA Technologies by 5.8% during the third quarter. Victory Capital Management Inc. now owns 259,143 shares of the company’s stock worth $1,749,000 after buying an additional 14,286 shares during the last quarter. Segall Bryant & Hamill LLC increased its holdings in SIGA Technologies by 1.8% during the third quarter. Segall Bryant & Hamill LLC now owns 325,136 shares of the company’s stock worth $2,195,000 after buying an additional 5,772 shares during the last quarter. Intech Investment Management LLC acquired a new position in SIGA Technologies during the third quarter worth $120,000. Finally, Foundry Partners LLC acquired a new position in SIGA Technologies during the third quarter worth $2,801,000. Institutional investors own 55.40% of the company’s stock.

SIGA Technologies Stock Down 1.7 %

Shares of SIGA stock opened at $5.64 on Friday. The company’s fifty day simple moving average is $5.93 and its 200-day simple moving average is $6.56. The firm has a market cap of $402.90 million, a PE ratio of 4.70 and a beta of 0.98. SIGA Technologies has a 12 month low of $5.16 and a 12 month high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings data on Tuesday, March 11th. The company reported $0.63 EPS for the quarter. The business had revenue of $81.40 million for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. On average, equities analysts predict that SIGA Technologies will post 1.04 earnings per share for the current fiscal year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.